Journal of Clinical Pediatrics >
Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B
Received date: 2023-08-07
Online published: 2024-09-04
Objective This study aimed to investigate the changes and the clinical implications of peripheral blood mucosal associated invariant T (MAIT) cells in children with chronic hepatitis B (CHB). Methods The investigation encompassed 20 patients with CHB and an equal number of age-matched healthy controls (HC). Peripheral blood specimens were obtained and analyzed using flow cytometry to quantify the presence of MAIT cells (defined as CD3+CD161+TCRVα7.2+), their subtypes, and the expression of various markers including PD-1, CD69, perforin, CD107α, CXCR3, CXCR6, and CCR6. Statistical comparisons between the groups were made using the Mann-Whitney U test and Spearman's correlation analysis. Results No significant differences were observed in the proportion of MAIT cells and their subtypes between the CHB and HC groups (P>0.05). However, the CHB group exhibited a significant increase in the proportion of MAIT cells expressing PD-1, CD69, CD107α, CXCR3, CXCR6, CCR6, and perforin (P<0.05). There was no significant correlation between the proportion of MAIT cells expressing CD69, PD-1, CD107α, perforin, CXCR6, CCR6 and CXCR3 and the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and hepatitis B virus (HBV) DNA fluorescent quantitation (P>0.05). Conclusion The distinct immunological functions of peripheral blood MAIT cells may contribute to the pathogenesis of CHB in pediatric patients.
Key words: mucosal associated invariant T cell; chronic hepatitis B; immunity; child
Tao JIANG , Shuangjie LI , Lian TANG , Wenxian OUYANG . Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B[J]. Journal of Clinical Pediatrics, 2024 , 42(9) : 787 -790 . DOI: 10.12372/jcp.2024.23e0751
[1] | Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study[J]. Lancet Gastroenterol Hepatoly, 2018, 3(6): 383-403. |
[2] | 张敏, 李静, 王福生. 儿童慢性乙型肝炎抗病毒治疗与临床治愈: 进展与挑战[J]. 中华肝脏病杂志, 2021, 29(12): 1218-1223. |
[3] | Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection[J]. Gut, 2012, 61(12): 1754-1764. |
[4] | 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中华传染病杂志, 2019, 37(12): 711-736. |
[5] | Tan HY, Yong YK, Ng CS, et al. Mucosal-associated invariant T cells: diplomatic front-runners in the fight against hepatitis B virus infection[J]. Crit Rev Immunol, 2021, 41(5): 1-16. |
[6] | Jahreis S, Boettcher S, von Lilienfeld-Toal M, et al. MAIT cell activation by fungal pathogens[J]. Methods Mol Biol, 2020, 2098: 167-177. |
[7] | Preeyaa SU, Murugesan A, Sopnajothi S, et al. Peripheral follicular T helper cells and mucosal-associated invariant T cells represent activated phenotypes during the febrile phase of acute dengue virus infection[J]. Viral Immunol, 2020, 33(9): 610-615. |
[8] | Boeijen LL, Montanari NR, Groen RA, et al. Mucosal-associated invariant T cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy[J]. J Infect Dis, 2017, 216(8): 969-976. |
[9] | Huang W, He W, Shi X, et al. Mucosal-associated invariant T-cells are severely reduced and exhausted in humans with chronic HBV infection[J]. J Viral Hepat, 2020, 27(11): 1096-1107. |
[10] | Yong YK, Saeidi A, Tan HY, et al. Hyper-expression of PD-1 is associated with the levels of exhausted and dysfunctional phenotypes of circulating CD161++ TCR iVα7.2+ mucosal-associated invariant T cells in chronic hepatitis B virus infection[J]. Front Immunol, 2018, 9: 472. |
[11] | Healy K, Pavesi A, Parrot T, et al. Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions[J]. JHEP Rep, 2021, 3(4): 100318. |
[12] | Shao L, Zhao H, Guo RF, et al. Biopsy-based single-cell transcriptomics reveals MAIT cells as potential targets for controlling fibrosis-related liver inflammation due to chronic hepatitis-B infection[J]. Clin Transl Med, 2022, 12(10): e1073. |
[13] | Yong YK, Tan HY, Saeidi A, et al. Decrease of CD69 levels on TCR Va7.2+ CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients[J]. Innate Immun, 2017, 23(5): 459-467. |
[14] | Dias J, Boulouis C, Gorin JB, et al. The CD4- CD8-MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool[J]. Proc Natl Acad Sci U S A, 2018, 115(49): E11513-E11522. |
[15] | Huang W, He W, Shi X, et al. The role of CD1d and MR1 restricted T cells in the liver[J]. Front Immunol, 2018, 9: 2424. |
[16] | Khanam A, Chua JV, Kottilil S. Immunopathology of chronic hepatitis B infection: Role of innate and adaptive immune response in disease progression[J]. Int J Mol Sci, 2021, 22(11): 5497. |
/
〈 |
|
〉 |